The life sciences industry underwent a turbulent 2023, with many companies experiencing challenges with raising funds, the window for IPOs tenuous, and companies reporting numerous layoffs. As a result, the life sciences industry was driven to explore creative strategies to reduce expenses to keep their businesses afloat, and in-house teams had to take a more commercially driven mindset to overcome continued budgeting pressures.

Dedicated to empowering legal teams with actionable solutions to enhance commercial success, we meticulously gathered top in-house professionals from across the life sciences sector. Together, we explored case studies on leveraging AI and cutting-edge legal technologies to streamline operations, navigated strategic opportunities in financing and M&As, and established innovative compliance protocols in response to evolving risks.